-
Signature
-
/s/ Katherine Huynh, Attorney-in-Fact for Amy Weaver
-
Stock symbol
-
CRM
-
Transactions as of
-
Jul 31, 2023
-
Transactions value $
-
-$1,118,682
-
Form type
-
4
-
Date filed
-
8/1/2023, 06:05 PM
Transactions Table
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
transaction |
CRM |
Common Stock |
Options Exercise |
$1.74M |
+11.5K |
+32.27% |
$151.14 |
47.1K |
Jul 31, 2023 |
Direct |
F1 |
transaction |
CRM |
Common Stock |
Options Exercise |
$772K |
+4.78K |
+10.15% |
$161.50 |
51.9K |
Jul 31, 2023 |
Direct |
F1 |
transaction |
CRM |
Common Stock |
Sale |
-$2.67M |
-12K |
-23.13% |
$222.72 |
39.9K |
Jul 31, 2023 |
Direct |
F1, F2 |
transaction |
CRM |
Common Stock |
Sale |
-$865K |
-3.87K |
-9.71% |
$223.40 |
36K |
Jul 31, 2023 |
Direct |
F1, F3 |
transaction |
CRM |
Common Stock |
Sale |
-$89.7K |
-400 |
-1.11% |
$224.13 |
35.6K |
Jul 31, 2023 |
Direct |
F1 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
transaction |
CRM |
Non-qualified Stock Option (Right to Buy) |
Options Exercise |
$0 |
-11.5K |
-14.64% |
$0.00 |
67K |
Jul 31, 2023 |
Common Stock |
11.5K |
$154.14 |
Direct |
F1, F4 |
transaction |
CRM |
Non-qualified Stock Option (Right to Buy) |
Options Exercise |
$0 |
-4.78K |
-20% |
$0.00 |
19.1K |
Jul 31, 2023 |
Common Stock |
4.78K |
$161.50 |
Direct |
F1, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: